1-4 of 4
Ralph Arlinghaus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bcr-Abl-Mediated Suppression of Normal Hematopoiesis in Chronic Myeloid Leukemia: Involvement of a Modified Form of NGAL.

Hui Lin, MD, Xiaohong Leng, PhD, Tong Sun, MS, Giuseppe Monaco, MD, Clifton Stephens, DVM, PhD, John Belmont, MD, PhD, Ralph Arlinghaus, PhD
Journal: Blood
Blood (2005) 106 (11): 2869.
https://doi.org/10.1182/blood.V106.11.2869.2869
Published: 2005
Journal Articles

BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571

Nicholas J. Donato, Ji Yuan Wu, Jonathan Stapley, Gary Gallick, Hui Lin, Ralph Arlinghaus, Moshe Talpaz
Journal: Blood
Blood (2003) 101 (2): 690–698.
https://doi.org/10.1182/blood.V101.2.690
Published: 2003
Journal Articles

Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome–positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses

Clinical Trials & Observations Brief Report
Hagop M. Kantarjian, Jorge E. Cortes, Susan O'Brien, Francis Giles, Guillermo Garcia-Manero, Stefan Faderl, Deborah Thomas, Sima Jeha, Mary Beth Rios, Laurie Letvak, Kathy Bochinski, Ralph Arlinghaus, Moshe Talpaz
Journal: Blood
Blood (2003) 101 (1): 97–100.
https://doi.org/10.1182/blood-2002-02-0545
Published: 2003
Journal Articles

Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia

Clinical Trials & Observations
Hagop M. Kantarjian, Susan O'Brien, Jorge E. Cortes, Sergio A. Giralt, Mary Beth Rios, Jianqin Shan, Francis J. Giles, Deborah A. Thomas, Stefan Faderl, Marcos De Lima, Guillermo Garcia-Manero, Richard Champlin, Ralph Arlinghaus, Moshe Talpaz
Journal: Blood
Blood (2002) 100 (5): 1590–1595.
https://doi.org/10.1182/blood.V100.5.1590.h81702001590_1590_1595
Published: 2002